Trial
NCT00911053
Melatonin for Circadian Sleep Disorders in the Blind
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Oregon Health and Science University
Collaborators
—
Condition
Insomnia
Intervention
Melatonin
Why stopped
Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-27